540 related articles for article (PubMed ID: 8827356)
1. Metabolites of a tobacco-specific nitrosamine, 4-(methylnitrosamino)- 1-(3-pyridyl)-1-butanone (NNK), in the urine of smokeless tobacco users: relationship between urinary biomarkers and oral leukoplakia.
Kresty LA; Carmella SG; Borukhova A; Akerkar SA; Gopalakrishnan R; Harris RE; Stoner GD; Hecht SS
Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):521-5. PubMed ID: 8827356
[TBL] [Abstract][Full Text] [Related]
2. Quantitation of metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone after cessation of smokeless tobacco use.
Hecht SS; Carmella SG; Ye M; Le KA; Jensen JA; Zimmerman CL; Hatsukami DK
Cancer Res; 2002 Jan; 62(1):129-34. PubMed ID: 11782369
[TBL] [Abstract][Full Text] [Related]
3. Analysis of human urine for pyridine-N-oxide metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco-specific lung carcinogen.
Carmella SG; Borukhova A; Akerkar SA; Hecht SS
Cancer Epidemiol Biomarkers Prev; 1997 Feb; 6(2):113-20. PubMed ID: 9037562
[TBL] [Abstract][Full Text] [Related]
4. Uptake and metabolism of carcinogenic levels of tobacco-specific nitrosamines by Sudanese snuff dippers.
Murphy SE; Carmella SG; Idris AM; Hoffmann D
Cancer Epidemiol Biomarkers Prev; 1994; 3(5):423-8. PubMed ID: 7920210
[TBL] [Abstract][Full Text] [Related]
5. Analysis of N- and O-glucuronides of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human urine.
Carmella SG; Le Ka KA; Upadhyaya P; Hecht SS
Chem Res Toxicol; 2002 Apr; 15(4):545-50. PubMed ID: 11952341
[TBL] [Abstract][Full Text] [Related]
6. Intraindividual and interindividual differences in metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers' urine.
Carmella SG; Akerkar SA; Richie JP; Hecht SS
Cancer Epidemiol Biomarkers Prev; 1995 Sep; 4(6):635-42. PubMed ID: 8547830
[TBL] [Abstract][Full Text] [Related]
7. Metabolism of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone to its biomarker total NNAL in smokeless tobacco users.
Hecht SS; Carmella SG; Stepanov I; Jensen J; Anderson A; Hatsukami DK
Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):732-5. PubMed ID: 18349296
[TBL] [Abstract][Full Text] [Related]
8. Differences in the urinary metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in black and white smokers.
Richie JP; Carmella SG; Muscat JE; Scott DG; Akerkar SA; Hecht SS
Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):783-90. PubMed ID: 9332760
[TBL] [Abstract][Full Text] [Related]
9. Analysis of total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human urine.
Carmella SG; Han S; Fristad A; Yang Y; Hecht SS
Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1257-61. PubMed ID: 14652291
[TBL] [Abstract][Full Text] [Related]
10. Biomonitoring of environmental tobacco smoke (ETS)-related exposure to 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK).
Michael Meger Irmtrud Meger-Kossien Kirsten Riedel Gerhard Scherer
Biomarkers; 2000; 5(1):33-45. PubMed ID: 23885904
[TBL] [Abstract][Full Text] [Related]
11. Quantitation of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation.
Hecht SS; Carmella SG; Chen M; Dor Koch JF; Miller AT; Murphy SE; Jensen JA; Zimmerman CL; Hatsukami DK
Cancer Res; 1999 Feb; 59(3):590-6. PubMed ID: 9973205
[TBL] [Abstract][Full Text] [Related]
12. Similar exposure to a tobacco-specific carcinogen in smokeless tobacco users and cigarette smokers.
Hecht SS; Carmella SG; Murphy SE; Riley WT; Le C; Luo X; Mooney M; Hatsukami DK
Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1567-72. PubMed ID: 17684130
[TBL] [Abstract][Full Text] [Related]
13. Metabolites of a tobacco-specific lung carcinogen in the urine of elementary school-aged children.
Hecht SS; Ye M; Carmella SG; Fredrickson A; Adgate JL; Greaves IA; Church TR; Ryan AD; Mongin SJ; Sexton K
Cancer Epidemiol Biomarkers Prev; 2001 Nov; 10(11):1109-16. PubMed ID: 11700257
[TBL] [Abstract][Full Text] [Related]
14. Tobacco-specific nitrosamines and their pyridine-N-glucuronides in the urine of smokers and smokeless tobacco users.
Stepanov I; Hecht SS
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):885-91. PubMed ID: 15824160
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of carcinogen exposure in people who used "reduced exposure" tobacco products.
Hatsukami DK; Lemmonds C; Zhang Y; Murphy SE; Le C; Carmella SG; Hecht SS
J Natl Cancer Inst; 2004 Jun; 96(11):844-52. PubMed ID: 15173268
[TBL] [Abstract][Full Text] [Related]
16. Association between Glucuronidation Genotypes and Urinary NNAL Metabolic Phenotypes in Smokers.
Chen G; Luo S; Kozlovich S; Lazarus P
Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1175-1184. PubMed ID: 27197298
[TBL] [Abstract][Full Text] [Related]
17. Stereochemistry of metabolites of a tobacco-specific lung carcinogen in smokers' urine.
Carmella SG; Ye M; Upadhyaya P; Hecht SS
Cancer Res; 1999 Aug; 59(15):3602-5. PubMed ID: 10446969
[TBL] [Abstract][Full Text] [Related]
18. Tobacco-specific N-nitrosamines and Areca-derived N-nitrosamines: chemistry, biochemistry, carcinogenicity, and relevance to humans.
Hoffmann D; Brunnemann KD; Prokopczyk B; Djordjevic MV
J Toxicol Environ Health; 1994 Jan; 41(1):1-52. PubMed ID: 8277523
[TBL] [Abstract][Full Text] [Related]
19. Metabolites of a tobacco-specific lung carcinogen in nonsmoking women exposed to environmental tobacco smoke.
Anderson KE; Carmella SG; Ye M; Bliss RL; Le C; Murphy L; Hecht SS
J Natl Cancer Inst; 2001 Mar; 93(5):378-81. PubMed ID: 11238699
[TBL] [Abstract][Full Text] [Related]
20. Effects of watercress consumption on metabolism of a tobacco-specific lung carcinogen in smokers.
Hecht SS; Chung FL; Richie JP; Akerkar SA; Borukhova A; Skowronski L; Carmella SG
Cancer Epidemiol Biomarkers Prev; 1995 Dec; 4(8):877-84. PubMed ID: 8634661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
